Clinical Outcomes of Metastasis-directed Therapy for Oligo-metastatic Prostate Cancer Diagnosed Using PSMA-PET/CT or Whole-body MRI
MDT for oligo-metastatic PCa diagnosed using next-generation imaging modalities in a Japanese population can result in favorable disease-free and survival outcomes with acceptable morbidities.
Authors
- Kiyonao Nakamura (ORCID: https://orcid.org/0000-0001-8660-4363)
- Tomoaki Otani (ORCID: https://orcid.org/0000-0002-4442-226X)
- Ryusuke Nakamoto (ORCID: https://orcid.org/0000-0003-4950-6654)
- Takashi Mizowaki (ORCID: https://orcid.org/0000-0002-8135-8746)
- Kaoru Murakami (ORCID: https://orcid.org/0000-0001-8852-2281)
- Yuki Kita (ORCID: https://orcid.org/0000-0002-6942-9695)
- Rihito Aizawa (ORCID: https://orcid.org/0000-0001-7098-6221)
- Yoichi Shimizu (ORCID: https://orcid.org/0000-0002-5154-090X)
- Yuji Nakamoto (ORCID: https://orcid.org/0000-0001-5783-8048)
- Kei Mizuno (ORCID: https://orcid.org/0000-0002-1273-5288)
- Takayuki Sumiyoshi (ORCID: https://orcid.org/0000-0001-5321-6014)
- Takashi Kobayashi (ORCID: https://orcid.org/0000-0002-7240-4851)
- Takayuki Goto (ORCID: https://orcid.org/0000-0001-6537-3068)
- Takashi Ogata (ORCID: https://orcid.org/0000-0002-6453-6408)
Institutions
- Kyoto University (JP)
- Kyoto City Hospital (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-05-27
- DOI
- https://doi.org/10.21873/anticanres.17623
- Citations
- 4
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 6.07
Funders
- Japan Society for the Promotion of Science